Westmead Millennium Institute logo  

 

 

Scientist workingOur Vision

 

The Westmead Millennium Institute will continue to grow as a world leader in medical research with the power to improve the health of all mankind.

 

Our "Bench to Bedside" philosophy will ensure that our research outcomes are rapidly translated into better prevention strategies, treatments and healthcare for all.

News

Eyes provide clues to a common cause of stroke

Healthy RetinaIn a groundbreaking study researchers have concluded that evidence of the cause of "lacunar stroke" can be found by looking at the back of a patient's eyes. Click here for more information.

A/Professor Graham Mann discusses melanoma

A/Professor Graham MannA/Professor Graham Mann discussed melonoma with 702 Breakfast presenter Adam Spencer on 25/5/09. Click here to hear the interview (1039Kb Wave sound file).

WMI Researchers receive top cancer awards

Click here for more information on awards to the following WMI researchers: Dr Rosemary Balleine from Translational Oncology; Dr Liang Qiao and Dr Sarah Walker from the Storr Liver Unit, and all staff from the Sydney Melanoma Unit.

$30 million boost for new WMI Building

Existing WMI Building

The NSW Government will provide $30 million in additional funding towards the development of a new building for WMI that will consolidate a major health knowledge asset for the people of Western Sydney. Click here for more (PDF, 24Kb)

Links

 

The Westmead Millennium Institute is one of the largest medical research institutes in Australia with over 420 staff conducting research into a wide range of important human disorders affecting both adults and children.

 

Our research spans:

  • infectious and immune diseases
  • cancer and leukaemia
  • liver and metabolic diseases
  • eye and brain-related disorders
  • heart and respiratory disorders.

Closely affiliated with both Westmead Hospital and the University of Sydney, our research extends from the laboratory to the patient, using the basic tools of molecular and cell biology, genetic epidemiology, imaging technology and clinical research.

 

This ‘Bench to Bedside’ approach enables greater translation of research from biomedical discovery to the development of new prevention strategies, diagnostics and more effective treatments.

 

Research in focus - July 2009

Dr David Booth

David Harris is Professor of Medicine and Associate Dean and Head of Western Clinical School. He is Director of the Renal Failure Laboratory in the Centre for Transplantation and Renal Research, Westmead Millennium Institute, and a nephrologist at Westmead and Blacktown Hospitals.


 

Paul Mitchell is a medical retinal specialist and professor of ophthalmology at the University of Sydney, and Director of Ophthalmology for the Sydney West Area. His clinical work focuses on the management of AMD, diabetic and other vascular retinopathies and on systemic diseases and their effects on the eye.

 

| The University of Sydney

| Breast Cancer Tissue Bank

| Core Technology Platforms

| PhD Opportunities |


 

Search this site

 

 
 
 

 

 

 


| Home | About Us | Research | Our People | The Millennium Foundation | News & Events | Contact Us | Search |

 


© 2000-2008 Westmead Millennium Institute